Genomic Vision
Paris
About Genomic Vision
Genomic Vision is a biotechnology company that combines pioneering Molecular Combing, a proprietary single DNA molecule detection technology, with biomarker discovery to develop and commercialize novel genetic tests and research tools for life sciences. Genomic Vision’s products focus on DNA analysis and genetic testing in the fields of cancer, rare inherited disorders and pharmacogenomics.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Public
- Employees: 51 – 100
- Estimated revenue: Less than $1M
- Total funding: $8.7M
- Funding stage: IPO
- Last round: Series B (Jul 2008)
- Ticker: epa:GV
- Website: genomicvision.com
- Phone: 33(0)155-422-929
Industries & Categories
Biotechnology, Genetics
Social Profiles
Canonical: https://fsome.com/organization/genomic-vision-2023545 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.